Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing bacteria in intensive care units of sanandaj general hospitals (Kurdistan, Iran)

Chemotherapy

Volumn 55, Issue 4, 2009, Pages 287-292

  Ramazanzadeh, Rashid ^a   Chitsaz, Mohsen ^b   Bahmani, Nasrin ^a  

^a KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

Extended spectrum lactamase; Gram negative bacteria; Intensive care units

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE CTX M; BETA LACTAMASE OXA 1; BETA LACTAMASE OXA 2; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; NALIDIXIC ACID; NORFLOXACIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; ENTEROBACTER; ESCHERICHIA COLI; FLAVIMONAS ORYZIHABITANS; GENERAL HOSPITAL; GRAM NEGATIVE BACTERIUM; INFECTION CONTROL; INTENSIVE CARE UNIT; IRAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS; RESPIRATORY TRACT INFECTION; SERRATIA MARCESCENS; SKIN INFECTION; SOFT TISSUE INFECTION; STATISTICAL ANALYSIS; STENOTROPHOMONAS MALTOPHILIA; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BLOOD; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HOSPITALS, GENERAL; HUMANS; INTENSIVE CARE UNITS; IRAN; MICROBIAL SENSITIVITY TESTS; RESPIRATORY SYSTEM; SKIN; URINARY TRACT;

EID: 66749151405     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000224656     Document Type: Article

References (33)

1. Gunseren F, Mamikoglu L, Ozturk S, Yucesoy M, Biberoglu K, Yulug N, Doganay M, Sumerkan B, Kocagoz S, Unal S, Cetin S, Calangu S, Koksal I, Leblebicioglu H, Gunaydin M: A surveillance study of antimicrobial resistance of gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey. J Antimicrob Chemother 1999;43:373-378.
2. Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP: Emerging resistance among bacterial pathogens in the intensive care unit - a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 2004;3:14.
3. Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM: Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study. Am J Infect Control 2007;35:606-612.
4. Kotapati S, Kuti JL, Nightingale CH, Nicolau DP: Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness. J Infect 2005;51:211-217.
5. Weber DJ, Raasch R, Rutala WA: Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens. Chest 1999;115:34S-41S.
6. Manzur A, Tubau F, Pujol M, Calatayud L, Dominguez MA, Pena C, Sora M, Gudiol F, Ariza J: Nosocomial outbreak due to extended-spectrum-beta-lactamase- producing Enterobacter cloacae in a cardiothoracic intensive care unit. J Clin Microbiol 2007;45:2365-2369.
7. Tonkic M, Goic-Barisic I, Punda-Polic V: Prevalence and antimicrobial resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae strains isolated in a university hospital in Split, Croatia. Int Microbiol 2005;8:119-124.
8. Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM: Predictors of mortality among patients with community-onset infection due to extendedspectrum beta-lactamase-producing Escherichia coli in Thailand. Infect Control Hosp Epidemiol 2008;29:80-82.
9. Jamal W, Rotimi VO, Khodakhast F, Saleem R, Pazhoor A, Al Hashim G: Prevalence of extended-spectrum beta-lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as determined by the VITEK 2 and E test systems in a Kuwait teaching hospital. Chemotherapy 2008;14:325-331.
10. Mendelson G, Hait V, Ben-Israel J, Gronich D, Granot E, Raz R: Prevalence and risk factors of extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis 2005;24:17-22.
11. Moreno A, Bello H, Guggiana D, Dominguez M, Gonzalez G: Extended-spectrum betalactamases belonging to CTX-M group produced by Escherichia coli strains isolated from companion animals treated with enrofloxacin. Vet Microbiol 2008;129:203-208.
12. Paterson DL: Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 2006;34:S20-S28, S64-S73.
13. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard, ed 9. Wayne, Clinical and Laboratory Standards Institute, 2006.
14. Jarlier V, Nicolas MH, Fournier G, Philippon A: Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867-878.
15. Yao F, Qian Y, Chen S, Wang P, Huang Y: Incidence of extended-spectrum beta-lactamases and characterization of integrons in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Shantou, China. Acta Biochim Biophys Sin (Shanghai) 2007;39:527-532.
16. Gupta E, Mohanty S, Sood S, Dhawan B, Das BK, Kapil A: Emerging resistance to carbapenems in a tertiary care hospital in north India. Indian J Med Res 2006;124:95-98.
17. Al-Zarounia M, Senokb A, Rashida F, AlJesmia SM, Panigrahib D: Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Chemotherapy 2008;17:32-36.
18. Kocazeyb BS: Antimicrobial resistance surveillance of gram-negative bacteria isolated from intensive care units of four different hospitals in Turkey: evaluation of the prevalence of extended-spectrum and inducible beta-lactamases using different E-test strips and direct induction methods. Chemotherapy 2001;47:396-408.
19. Mehrgan H, Rahbar M: Prevalence of extended-spectrum [beta]-lactamase- producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int J Antimicrob Agents 2008;31:147-151.
20. Mirsalehian A, Nakhjavani F, Peymani A, Jabal Ameli F, Mirafshar SM, Hamidian M: Frequency of extended spectrum β-lactamase producing Enterobacteriaceae in intensive care units. Tehran Univ Med J 2007;1:33-38.
21. Paterson DL, Ko W-C, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, Bonomo RA, Rice LB, McCormack JG, Yu VL: Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001;39:2206-2212.
22. Paterson DL, Yu VL: Extended spectrum lactamases: a call for improved detection and control. Clin Infect Dis 1999;29:1419-1422.
23. Bush K: Extended-spectrum beta-lactamases in North America, 1987-2006. Clin Microbiol Infect 2008;14(suppl 1):134-143.
24. Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM: Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008;14(suppl 1):144-153.
25. Al-Tawfiq JA, Anani AA: Antimicrobial susceptibility pattern of bacterial pathogens causing urinary tract infections in a Saudi Arabian hospital. Chemotherapy 2009;55:127-131.
26. Feizabadi MM, Etemadi G, Yadegarinia D, Rahmati M, Shabanpoor S, Bokaei S: Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran. Med Sci Monit 2006;12:BR362-BR365.
27. Hawkey PM: Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect 2008; 14(suppl 1):159-165.
28. Villegas MV, Kattan JN, Quinteros MG, Casellas JM: Prevalence of extended-spectrum beta-lactamases in South America. Clin Microbiol Infect 2008;14(suppl 1):154-158.
29. Chu YW, Cheung TK, Wong CH, Tsang GK, Lee K, Lau SS, Kam KM: Quinolone resistance and correlation to other antimicrobial resistances in faecal isolates of Escherichia coli in Hong Kong. Chemotherapy 2008;54:274-278.
30. Shahcheraghi F, Moezi H, Feizabadi MM: Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran. Med Sci Monit 2007;13:BR247-BR250.
31. Zhao WH, Hu ZQ, Chen G, Ito R, Shimamura T: Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations. Chemotherapy 2008;54:31-37.
32. Machado E, Ferreira J, Novais A, Peixe L, Canton R, Baquero F, Coque TM: Preservation of integron types among Enterobacteriaceae producing extended-spectrum beta-lactamases in a Spanish hospital over a 15-year period (1988-2003). Antimicrob Agents Chemother 2007;51:2201-2204.
33. Moland ES, Hong SG, Thomson KS, Larone DH, Hanson ND: Klebsiella pneumoniae isolate producing at least eight different beta-lactamases, including AMPC and KPC beta-lactamases. Antimicrob Agents Chemother 2007;51:800-801